Isabel Figueroa
Amgen (United States)(US)Gilead Sciences (United States)(US)Instituto Politécnico Nacional(MX)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, Protein Degradation and Inhibitors
Most-Cited Works
- → Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity(2019)185 cited
- → Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin(2012)145 cited
- → Discovery of Pyrophosphate Diesters as Tunable, Soluble, and Bioorthogonal Linkers for Site-Specific Antibody–Drug Conjugates(2016)139 cited
- → Development of Anti-CD74 Antibody–Drug Conjugates to Target Glucocorticoids to Immune Cells(2018)57 cited
- → Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy(2020)55 cited
- → Antibody Drug Conjugates: Application of Quantitative Pharmacology in Modality Design and Target Selection(2015)36 cited